Elite Pharmaceuticals Inc (ELTP): Free Cash Flow
$22.82M
Year ended 2026-03-31
$17.53M
Trailing 12 months to 2026-06-30
| Period ended | Free Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2026-03-31 | $22.82M | +291.4% | 2026-06-29, From 2025-04-01 |
| 2025-03-31 | $5.83M | n/m | 2026-06-29, From 2024-04-01 |
| 2024-03-31 | -$4.04M | n/c | 2025-06-30, From 2023-04-01 |
| 2023-03-31 | -$2.40M | n/m | 2024-07-01, From 2022-04-01 |
| 2022-03-31 | $6.01M | n/a | 2023-06-29, From 2021-04-01 |
Free Cash Flow at similar companies
| Company | Year ended | Free Cash Flow | Change YoY |
|---|---|---|---|
| Elite Pharmaceuticals Inc (ELTP) | 2026-03-31 | $22.82M | +291.4% |
| Macrogenics Inc (MGNX) | 2025-12-31 | -$82.95M | n/m |
| Karyopharm Therapeutics Inc. (KPTI) | 2025-12-31 | -$75.37M | n/m |
| Heron Therapeutics, Inc. (HRTX) | 2025-12-31 | -$27.91M | n/m |
| Liquidia Corp (LQDA) | 2025-12-31 | -$40.02M | n/m |
| Lifecore Biomedical, Inc. (LFCR) | 2025-05-25 | -$13.62M | n/m |
| Syndax Pharmaceuticals Inc (SNDX) | 2025-12-31 | -$323.17M | n/m |
| Phathom Pharmaceuticals, Inc. (PHAT) | 2025-12-31 | -$167.00M | n/m |
| Cryoport, Inc. (CYRX) | 2025-12-31 | -$25.02M | n/m |
Compare ELTP, MGNX, KPTI, HRTX side by side · Screen every company in Pharmaceutical Preparations ↗